| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. | Clin Infect Dis | 2008 | 5.39 |
| 2 | Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections. | Clin Infect Dis | 2012 | 2.11 |
| 3 | Prospective monitoring of cefepime in intensive care unit adult patients. | Crit Care | 2010 | 1.18 |
| 4 | Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods. | Antimicrob Agents Chemother | 2006 | 1.09 |
| 5 | Liquid chromatography-mass spectrometry method for quantification of caspofungin in clinical plasma samples. | J Mass Spectrom | 2007 | 0.85 |